| Peer-Reviewed

Flavonoid-Rich Fraction of Alstonia boonei Leaves Attenuates Haematological and Biochemical Changes Induced by Plasmodium berghei-Infection

Received: 29 April 2022    Accepted: 14 May 2022    Published: 8 June 2022
Views:       Downloads:
Abstract

Malaria has become a global scourge, particularly in the developing nations of the world. However, efforts to combat the malaria scourge have been hampered by the ability of plasmodium species to develop resistance to conventional anti-malarial drugs such as chloroquine and artemisinin. This necessitates the search for newer anti-malarial agents from other sources such as medicinal plants. This study investigated the anti-malarial activity of flavonoid-rich fraction of Alstonia boonei leaves (FRFABL) on haematological and various biochemical changes induced by plasmodium berghei-infected mice following a 5-day suppressive test. Forty eight (48) adult albino Wistar mice of average body weight of 30 ± 38 g were used for this study; 18 for the toxicity study while 30 mice consisting of six groups of five mice each were used for the anti-malarial study. Groups 4-6 were infected malaria and treated with 200, 400 and 600 mg/kg body weight of FRFABL respectively; group 3 mice was infected malaria and treated with 140 mg/kg body weight of Coartem® (standard anti-malarial drug); group 2 was infected malaria and no treatment (positive control) while group 1 was not infected and served as normal control. Quantitative phytochemical screening of FRFABL revealed high amounts of phenols, alkaloids and flavoinoids. Tannins and terpenoids were detected in moderate amounts, whereas steroids and saponins were found in smaller amounts. After oral administration of 5000 mg/kg body weight, the toxicity test revealed that FRFABL was not toxic. It was observed that the percentage parasitemia of mice in Group 2 was significantly (p < 0.05) higher when compared to mice in parasitized and treated groups. When compared to the positive control (group 2), the treated groups showed significant (p < 0.05) increases in packed cell volume (PCV), haemoglobin (Hb) concentrations, and red blood cell (RBC) count, but the white blood cell (WBC) count decreased significantly (p < 0.05) in the treated groups when compared to the positive control (group 2). Similarly, FRFABL treatment of infected mice significantly (p < 0.05) restored some malaria-modified biochemical parameters of plasmodium berghei-infected mice. The results showed that FRFABL possesses good anti-malarial properties and will serve as an excellent anti-malarial agent.

Published in Advances in Biochemistry (Volume 10, Issue 2)
DOI 10.11648/j.ab.20221002.15
Page(s) 71-80
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

FRFABL, Malaria, Biochemical Parameters, FRFABL Plasmodium berghei

References
[1] Centers for Disease Control and Prevention: CDC’s Malaria Program. (2021) Available online: https://www.cdc.gov/malaria/ resources/pdf/fsp/cdc_malaria_program_2021.pdf (accefssed on 4th April, 2022).
[2] WHO. (2020) World Malaria Report 2020. Available online: https://www.who.int/teams/global-malariaprogramme/reports/world-malaria-report-2020 (accessed on 25th March, 2022).
[3] Tse E. G., Korsik M., and Todd M. H. (2019) The past, present and future of anti-malarial medicines. Malaria Journal, 18, 93.
[4] Arya A., Foko L. P. K., Chaudhry S., Sharma A., and Singh V. (2020) Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systemic review of clinical studies from two malaria endemic regions–India and Sub-Saharan Africa. International Journal for Parasitology – Drugs and Drug Resistance, 15, 43-56.
[5] Singh S. K., and Singh S. A. (2014) Brief History of Quinoline as Antimalarial Agents. International Journal of Pharmaceutical Sciences Review and Research, 50, 295-302.
[6] O’Neill P. M., Barton V. E., Ward S. A., and Chadwick, J. (2012) Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use; Springer Science and Business Media: Basel, Switzerland.
[7] Hailemeskel E., Kassa M., Taddesse G., Mohammed H., Woyessa A., Tasew G., Sleshi M., Kebede A., and Petros B. (2013) Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia. Acta Tropica, 128, 636-641.
[8] Vanshika L., Manoj K. D., Neeru S., Vas D., Wajihullah K., and Yagya D. S. (2011) Multiple Origins of Plasmodium falciparum Dihydropteroate Synthetase Mutant Alleles Associated with Sulfadoxine Resistance in India. Antimicrobial Agents and Chemotherapy, 55, 2813-2817.
[9] WHO. (2021) World malaria report 2021. Geneva: (https:// https://reliefweb.int/report/world/world-malaria-report-2021, accessed 28 April, 2022).
[10] WHO. (2019) World malaria report 2019. Geneva: (https://apps.who.int/iris/bitstream/handle/10665/330011/9789241565721-eng.pdf, accessed 13 April, 2022).
[11] Cowman A. F., Berry D., and Baum J. (2012) The cellular and molecular basis for malaria parasite invasion of the human red blood cell. Journal of Cell Biology, 198 (6), 961–971.
[12] Wan Y. D., Zang Y. D., and Wang J. S. (1992) Studies on the antimalarial action of gelatin capsule of Artemisia annua. Zongguo ji sheng chong xue yu ji sheng chong bing za shi. Chinese Journal of Parasitology and Parasitic Diseases, 10, 290-294.
[13] Wright C. W., Linley P. A., Brun R., Wittlin S., and Hsu E. (2010). Ancient Chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of Qing Hao with potent antimalarial activity. Molecules, 15, 804-812.
[14] Rasoanaivo P., Wright C. W., Willcox M. L., and Gilbert B. (2011) Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malaria Journal, 10 (Suppl. 1), S4.
[15] Enechi O. C., Amah C. C., Okagu I. U., Ononiwu C. P., Azidiegwu V. C., Ugwuoke E. O., Onoh A. P., and Ndukwe E. E. (2019) Methanol extracts of Fagara zanthoxyloides leaves possess antimalarial effects and normalizes haematological and biochemical status of Plasmodium berghei-passaged mice. Pharmaceutical Biology, 57 (1), 577-585.
[16] Amah C. C., Enechi O. C., Ekpo D. E., Okagu I. U., Ononiwu C. P., Joshua P. E. (2021) Safety assessment and antimalarial property of methanol extract of Fagara zanthoxyloides root-bark on Plasmodium berghei-infected mice. Comparative Clinical Pathology, 1-12.
[17] Iwu M. M. (1993) Handbook of African Medicinal Plants. CRC Press, Boca Raton, FL, USA, pp. 116-118.
[18] Ojewole J. A. O. (1984) Studies on the pharmacology echitamine, an alkaloid from the stem bark of Alstonia boonei (Apocynaceae). International journal of crude drug research, 22, 121-143.
[19] Koumaglo K., Gbeassor M., Nikabu O., de Souza C. and Werner W. (1992) Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum. Planta Medica, 58, 533-534.
[20] Asuzu I. U., and Anaga A. O. (1991) Pharmacological screenings of the aqueous extract of Alstonia boonei stem bark. Fitoter, 63, 411-417.
[21] Obih P. O., Makinde J. M., and Laoye J. O. (1985) Investigations of various extracts of Morinda lucida for antimalaraial actions on Plasmodium berghei in mice. African Journal of Medicine and Medical Sciences, 14, 45-49.
[22] Noronha M., Pawar V., Prajapati A., and Subramanian R. B. (2020) A literature review on traditional herbal medicines for malaria. South African Journal of Botany, 128, 292-303.
[23] Derrell C. (1996) Guide for care and use of laboratory animals. Institute of Laboratory Animal Resources. National Academy Press, Washington DC.
[24] Chu Y. F., Sun J., Wu X., and Liu R. H. (2002) Anti-oxidant and anti-proliferation activities of common vegetables. Journal of Agriculture and Food Chemistry, 50 (23), 6910-6.
[25] Trease G. E., and Evans W. C. (1989) Pharmacognosy. 13thEdn. Bailliere Tindall Books Publishers. By Cas Sell and Collines Macmillan Publishers Ltd. London. pp. 1-105.
[26] Harborne J. B. (1998) Textbook of phytochemical method, 3rd Edn. London: Champmaan and Hall Ltd.
[27] Lorke D. (1983) Determination of acute toxicity. Archives of Toxicity, 53, 275-279.
[28] Dacie J. V., and Lewis, S. M. (2000) Practical Haematology. 9th Edn Churchill Livingstone, England. pp. 485-489.
[29] Ochei J., and Kolhatkar A. (2008) Medical Laboratory Science Theory and Practice. McGraw Hill, New York. pp. 663-665.
[30] Briggs C., and Bain B. J. (2017) Basic haematological techniques. In: Dacie and Lewis practical haematology, 12th ed. Elsevier; p. 18-49.
[31] Reitman S., and Frankel S. (1957) A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28, 56-63.
[32] Klein B., Read P. A., and Babson A. L. (1960) Rapid method for the quantitative determination of serum alkaline phosphatase. Clinical chemistry, 6 (2), 269-275.
[33] Jendrassik L., and Grof P. (1938) A study of six representative methods of plasma bilirubin analysis. Journal of clinical pathology, 19 (1), 271.
[34] Allain C. C., Poon L. S., and Chain C. S. G. (1974) Enzymatic determination of total serum cholesterol. Clinical Chemistry, 20, 470-5.
[35] Albers J. J., Warnic G. R., and Cheung M. C. (1978) Qualification of high density lipoproteins. lipids, 13, 926-932.
[36] Wallin B., Rosengren B., Shertzer H. G., and Camejo G. (1993) Lipoprotein oxidation and measurement of TBARS formation in single micro litre plate; Its use for evaluation of antioxidants. Analytical Biochemistry, 208, 10-15.
[37] Xin Z., Waterman D. F., Henken R. M., and Harmon R. J. (1991) Effects of copper status on neutrophil function, superoxide dismutase and copper distribution in steers. Journal of Diary Sciences, 74, 3078-3082.
[38] Aebi H. E. (1983) Catalase. In: Bergmeyer, H. U. (Ed.). Methods of enzymatic analysis. Weinhem: Verlag Chemie; pp. 273- 86.
[39] King K. J., and Wootton I. D. P. (1959) Microanalysis in Medical Biochemistry. London: J and A. Churchill Ltd.
[40] Obiagwu M. O., Ihekwereme C. P., Ajaghaku D. L., and Okoye F. B. C. (2014) The useful medicinal properties of the root-bark extract of Alstonia boonei (Apocynaceae) may be connected to antioxidant activity. ISRN Pharmacology, 2014, 1-4.
[41] Freundlich J. S., Anderson J. W., Sarantakis D., Shieh H. M., Yu M., Valderramos J. C., Lucumi, E., Kuo M., Jacobs W. R., Fidock D. A., Schiehser G. A., Jacobus D. P., and Sacchettini J. C. (2005) Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase: part 1:4′-substituted triclosan derivatives. Bioorganic & Medicinal Chemistry Letters, 15, 5247-5252.
[42] Perozzo R., Kuo M., Sidhu A. B. S., Valiyaveettil J. T., Bittman R., Jacobs W. R., Fidock D. A., and Sacchettini J. C. (2002) Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. Journal of Biological Chemistry, 277, 13106-13114.
[43] Anorue E. C., and Ekpo D. E. (2020) Non-oxidative effects of the flavonoid-rich fraction of Lasianthera africana leaves on human haemoglobin. All Life, 13 (1), 658-667.
[44] Onwusonye J. C., and Uwakwe A. A. (2014) The antiplasmodial activity of methanol root bark extract of Alstonia boonei against Plasmodium berghei infection in mice. International Journal of Scientific Research, 3, 2199–2201.
[45] Onyishi G. C., Nwosu G. C., and Eyo J. E. (2020) In vivo studies on the biochemical indices of Plasmodium berghei infected mice treated with Alstonia boonei leaf and root extracts. African Health Scinces, 20 (4), 1698-1709.
[46] Ntie-Kang F., Onguéné P. A., Lifongo L. L., Ndom J. C., Sippl W., and Mbaze L. M. (2014) The potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoids. Malaria Journal, 13 (2014), 81.
[47] Opoku F., and Akoto O. (2014) Antimicrobial and phytochemical properties of Alstonia boonei extracts. Organic Chemistry Current Research, 4, 137.
[48] Igbenegbu C., and Odaibo A. B. (2013) Impairs of acute malaria on some hematological parameters in a Semi-Urban community in Southwestern Nigeria. Acta Parasitologica Globalis, 4 (1), 01-05.
[49] Onyishi G. C., Ugwu O. C., and Nwosu C. G. (2021) Comparative Anti-malaria Potentials of leaf and Root Extracts of Alstonia boonei on the Haematological Indices of mice infected with Plasmodium berghei. Animal Research International, 18 (1), 4005-4019.
[50] Francis U., Isaac Z., Yakubu A., Enosakhare A., and Felix E. (2014) Haematological parameters of malariaiInfected patients in the university of Calabar teaching hospital, Calabar, Nigeria. Journal of Hematology and Thromboembolic Diseases, 2, 171.
[51] Eledo B. O., and Izah S. C. (2018) Studies on Some Haematological Parameters among Malaria Infected Patients Attending a Tertiary Hospital in Nigeria. Open Access Blood Research and Transfusion Journal, 2 (3), 001-005.
[52] Momoh J., Longe A. O., Campbell C. A. (2014) In-vivo antiplasmodial and in-vitro antioxidant activity of ethanolic leaf extract of Alstonia boonei and its effect on some biochemical parameters in Swiss albino mice infected with Plasmodium berghei NK-65. European Science Journal, 10, 68–82.
[53] Enechi O. C., Amah C. C., Okagu I. U., Ononiwu P. C., Nweke A. C., Ugwuanyi T. C., Ajibo E. A., Nweze A. C., and Chukwurah, B. C. (2021) Sida acuta Burm. f. leaves ethanol extract ameliorates haematological and biochemical alterations induced by Plasmodium berghei ANKA-65 in mice. Clinical Phytoscience, 7 (78), 1-12.
[54] Malakouti M., Kataria A., Ali S. K., Schenker S., (2017) Elevated liver enzymes in asymptomatic patients-what should I do? Journal of Clinical and Translational Hepatology, 5 (4), 394–403.
[55] Ogugua V. N., Okagu I. U., Onuh O. M., and Uzoegwu P. N. (2019) Commercial herbal preparations ameliorate Plasmodium berghei NK65-induced aberrations in mice. Journal of Vector Borne Diseases, 56, 146-153.
[56] Tran P. N., Brown S. H. J., Rug M., Ridgway M. C., Mitchell T. W., and Maier A. G. (2016) Changes in lipid composition during sexual development of the malaria parasite Plasmodium falciparum. Malaria Journal, 15 (1), 73.
[57] Fabbri C., Mascarenhas-Netto R. C., and Lalwani P. (2013) Lipid peroxidation and antioxidant enzymes activity in Plasmodium vivax malaria patients evolving with cholestatic jaundice. Malaria Journal, 12, 315.
[58] Chuljerm H., Maneekesorn S., Somsak V., Ma Y., Srichairatanakool S., and Koonyosying P. (2021) Anti-Malarial and Anti-Lipid Peroxidation Activities of Deferiprone-Resveratrol Hybrid in Plasmodium berghei-Infected Mice. Biology, 10, 911.
[59] Narsaria N., Mohanty C., Das B. K., Mishra S. P., Prasad R. (2012) Oxidative Stress in Children with Severe Malaria. Journal of Tropical Pediatrics, 58, 147–150.
[60] Nsiah K., Bahaah B., Oppong Afranie B., Koffie S., Akowuah E., Donkor S. (2019) Oxidative Stress and Hemoglobin Level of Complicated and Uncomplicated Malaria Cases among Children: A Cross-Sectional Study in Kumasi Metropolis, Ghana. Journal of Tropical Medicine, 2019, 8479076.
Cite This Article
  • APA Style

    Osmund Chukwuma Enechi, Christian Chijioke Amah, Jacob Ikechukwu Okoro, Ursula Chidimma Obelenwa, Ernest Chinecherem Omeje, et al. (2022). Flavonoid-Rich Fraction of Alstonia boonei Leaves Attenuates Haematological and Biochemical Changes Induced by Plasmodium berghei-Infection. Advances in Biochemistry, 10(2), 71-80. https://doi.org/10.11648/j.ab.20221002.15

    Copy | Download

    ACS Style

    Osmund Chukwuma Enechi; Christian Chijioke Amah; Jacob Ikechukwu Okoro; Ursula Chidimma Obelenwa; Ernest Chinecherem Omeje, et al. Flavonoid-Rich Fraction of Alstonia boonei Leaves Attenuates Haematological and Biochemical Changes Induced by Plasmodium berghei-Infection. Adv. Biochem. 2022, 10(2), 71-80. doi: 10.11648/j.ab.20221002.15

    Copy | Download

    AMA Style

    Osmund Chukwuma Enechi, Christian Chijioke Amah, Jacob Ikechukwu Okoro, Ursula Chidimma Obelenwa, Ernest Chinecherem Omeje, et al. Flavonoid-Rich Fraction of Alstonia boonei Leaves Attenuates Haematological and Biochemical Changes Induced by Plasmodium berghei-Infection. Adv Biochem. 2022;10(2):71-80. doi: 10.11648/j.ab.20221002.15

    Copy | Download

  • @article{10.11648/j.ab.20221002.15,
      author = {Osmund Chukwuma Enechi and Christian Chijioke Amah and Jacob Ikechukwu Okoro and Ursula Chidimma Obelenwa and Ernest Chinecherem Omeje and Thankgod Ugochukwu Nweke and Mary Chiamaka Uzochukwu and Sixtus Chidozie Ezimora and Perpetua Chidimma Ike and Lovelyn Ngozika Eze and Chidubem Francis Okoye},
      title = {Flavonoid-Rich Fraction of Alstonia boonei Leaves Attenuates Haematological and Biochemical Changes Induced by Plasmodium berghei-Infection},
      journal = {Advances in Biochemistry},
      volume = {10},
      number = {2},
      pages = {71-80},
      doi = {10.11648/j.ab.20221002.15},
      url = {https://doi.org/10.11648/j.ab.20221002.15},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20221002.15},
      abstract = {Malaria has become a global scourge, particularly in the developing nations of the world. However, efforts to combat the malaria scourge have been hampered by the ability of plasmodium species to develop resistance to conventional anti-malarial drugs such as chloroquine and artemisinin. This necessitates the search for newer anti-malarial agents from other sources such as medicinal plants. This study investigated the anti-malarial activity of flavonoid-rich fraction of Alstonia boonei leaves (FRFABL) on haematological and various biochemical changes induced by plasmodium berghei-infected mice following a 5-day suppressive test. Forty eight (48) adult albino Wistar mice of average body weight of 30 ± 38 g were used for this study; 18 for the toxicity study while 30 mice consisting of six groups of five mice each were used for the anti-malarial study. Groups 4-6 were infected malaria and treated with 200, 400 and 600 mg/kg body weight of FRFABL respectively; group 3 mice was infected malaria and treated with 140 mg/kg body weight of Coartem® (standard anti-malarial drug); group 2 was infected malaria and no treatment (positive control) while group 1 was not infected and served as normal control. Quantitative phytochemical screening of FRFABL revealed high amounts of phenols, alkaloids and flavoinoids. Tannins and terpenoids were detected in moderate amounts, whereas steroids and saponins were found in smaller amounts. After oral administration of 5000 mg/kg body weight, the toxicity test revealed that FRFABL was not toxic. It was observed that the percentage parasitemia of mice in Group 2 was significantly (p plasmodium berghei-infected mice. The results showed that FRFABL possesses good anti-malarial properties and will serve as an excellent anti-malarial agent.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Flavonoid-Rich Fraction of Alstonia boonei Leaves Attenuates Haematological and Biochemical Changes Induced by Plasmodium berghei-Infection
    AU  - Osmund Chukwuma Enechi
    AU  - Christian Chijioke Amah
    AU  - Jacob Ikechukwu Okoro
    AU  - Ursula Chidimma Obelenwa
    AU  - Ernest Chinecherem Omeje
    AU  - Thankgod Ugochukwu Nweke
    AU  - Mary Chiamaka Uzochukwu
    AU  - Sixtus Chidozie Ezimora
    AU  - Perpetua Chidimma Ike
    AU  - Lovelyn Ngozika Eze
    AU  - Chidubem Francis Okoye
    Y1  - 2022/06/08
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ab.20221002.15
    DO  - 10.11648/j.ab.20221002.15
    T2  - Advances in Biochemistry
    JF  - Advances in Biochemistry
    JO  - Advances in Biochemistry
    SP  - 71
    EP  - 80
    PB  - Science Publishing Group
    SN  - 2329-0862
    UR  - https://doi.org/10.11648/j.ab.20221002.15
    AB  - Malaria has become a global scourge, particularly in the developing nations of the world. However, efforts to combat the malaria scourge have been hampered by the ability of plasmodium species to develop resistance to conventional anti-malarial drugs such as chloroquine and artemisinin. This necessitates the search for newer anti-malarial agents from other sources such as medicinal plants. This study investigated the anti-malarial activity of flavonoid-rich fraction of Alstonia boonei leaves (FRFABL) on haematological and various biochemical changes induced by plasmodium berghei-infected mice following a 5-day suppressive test. Forty eight (48) adult albino Wistar mice of average body weight of 30 ± 38 g were used for this study; 18 for the toxicity study while 30 mice consisting of six groups of five mice each were used for the anti-malarial study. Groups 4-6 were infected malaria and treated with 200, 400 and 600 mg/kg body weight of FRFABL respectively; group 3 mice was infected malaria and treated with 140 mg/kg body weight of Coartem® (standard anti-malarial drug); group 2 was infected malaria and no treatment (positive control) while group 1 was not infected and served as normal control. Quantitative phytochemical screening of FRFABL revealed high amounts of phenols, alkaloids and flavoinoids. Tannins and terpenoids were detected in moderate amounts, whereas steroids and saponins were found in smaller amounts. After oral administration of 5000 mg/kg body weight, the toxicity test revealed that FRFABL was not toxic. It was observed that the percentage parasitemia of mice in Group 2 was significantly (p plasmodium berghei-infected mice. The results showed that FRFABL possesses good anti-malarial properties and will serve as an excellent anti-malarial agent.
    VL  - 10
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Medical Parasitology, Toxicology and Drug Development Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Department of Microbiology, Alex Ekwueme Federal University, Ndufu-Alike, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Pharamacological Biochemistry Research Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

  • Sections